Lannett Company, Inc. clinical trials
Acquired by Aurobindo Pharma, Jun 29, 2026 · source ↗
The registry lists 3 studies whose lead sponsor is Lannett Company, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 15, 2022.
Before and after it joined Aurobindo Pharma
- First submitted before Lannett Company, Inc. became part of Aurobindo Pharma
- 3
- First submitted after Lannett Company, Inc. became part of Aurobindo Pharma
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Lannett Company, Inc.3 studies
Something wrong with this grouping? Tell us on the Aurobindo Pharma page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All Aurobindo Pharma studies →
- A Study to Demonstrate Pharmacokinetic and Pharmacodynamic Biosimilarity Between HEC-Glargine and US-Lantus® in Healthy Male VolunteersCompletedNCT05248841Phase 1
Sponsor listed in the registry: Lannett Company, Inc. · First submitted before Lannett Company, Inc. became part of Aurobindo Pharma
- Topical Application of Cocaine HCl 4%, or 10%, or Placebo Solution in Local (Topical) AnesthesiaCompletedNCT02500836Phase 3
Sponsor listed in the registry: Lannett Company, Inc. · First submitted before Lannett Company, Inc. became part of Aurobindo Pharma
- Topical Application of Cocaine HCl 4% and 10% on Safety and Efficacy in Local (Topical) AnesthesiaTerminatedNCT01746940Phase 3
Sponsor listed in the registry: Lannett Company, Inc. · First submitted before Lannett Company, Inc. became part of Aurobindo Pharma